Business · 11/03/1994Updated: 10/15/2026 · 1 min read
The Food and Drug Administration (FDA) and National Institute of Allergy and Infectious Diseases (NIAID) Announce Public Workshop on Clinical Trial Design Issues of Liposomal Antifungal Agents
Summary
The FDA and NIAID are hosting a public workshop to discuss clinical trial design issues of liposomal antifungal agents, aiming to assist pharmaceutical sponsors in designing study protocols and expediting drug development.
Original source language: Federal Register — Health and Human ServicesOpen original release →